Kidney Function and Use of Recommended Medications after Myocardial Infarction in Elderly Patients
Open Access
- 1 July 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 1 (4), 796-801
- https://doi.org/10.2215/cjn.00150106
Abstract
Several studies have found reduced use of recommended medications after myocardial infarction (MI) in patients with impaired kidney function. However, the reasons for such undertreatment are not well understood. A total of 1380 Medicare patients who survived at least 90 d after MI and had prescription drug coverage through Pennsylvania’s medication assistance program for the elderly were studied. Filled prescriptions were used to assess use of angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), β blockers, and statins within 90 d of MI. Patients’ demographics, comorbidities, and health care utilization before MI also were ascertained. We used logistic regression to test the association between kidney function and postdischarge use of each medication. Overall, 619 (45%) patients filled a prescription for a β blocker, 675 (49%) received an ACEI or ARB, and 406 (29%) received a statin after discharge but within 90 d after their admission for MI. Reduced kidney function was associated with both lower β blocker and statin use (P = 0.01 and P = 0.002, respectively), but after multivariate adjustment, these associations disappeared (P = 0.23 and P = 0.62, respectively). Use of ACEI or ARB was nearly half in patients with estimated GFR P < 0.001). Analyses using serum creatinine measurements rather than estimations of GFR yielded similar results. Differences in other characteristics such as age, rather than kidney function, may be responsible for much or all the reported reduction in use of preventive medications after MI seen in patients with chronic kidney disease.This publication has 23 references indexed in Scilit:
- Underuse of ACE Inhibitors and Angiotensin II Receptor Blockers in Elderly Patients With DiabetesAmerican Journal of Kidney Diseases, 2005
- Identification of Individuals With CKD From Medicare Claims Data: A Validation StudyAmerican Journal of Kidney Diseases, 2005
- Effects of Noncardiovascular Comorbidities on Antihypertensive Use in Elderly HypertensivesHypertension, 2005
- Cardiovascular Mortality Risk in Chronic Kidney DiseaseJAMA, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationThe New England Journal of Medicine, 2004
- “Renalism”Journal of the American Society of Nephrology, 2004
- Accuracy of medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital recordsAmerican Heart Journal, 2004
- Editorial boardAmerican Journal of Kidney Diseases, 2003
- Clinical Subtypes of Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 1998
- Effect of Long-Term Therapy with Captopril on Proteinuria and Renal Function in Patients with Non-Insulin-Dependent Diabetes and with Non-Diabetic Renal DiseasesNephron, 1995